Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002274,GO:0002274,myeloid leukocyte activation,16/81,232/18800,2.8393145833564804e-15,6.893855808389529e-12,4.0019391864361296e-12,C1QA/CLEC4D/CSF1/CXCL8/HAVCR2/IFNGR1/IL10/IL15/IL4R/LILRB4/LTBR/NECTIN2/PRG3/PTGDS/TNF/VSIG4,16
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,20/81,486/18800,1.31823702177562e-14,1.6003397444356e-11,9.29010195872397e-12,CCL11/CCL20/CSF1/CXCL8/CXCL9/FAS/IFNGR1/IL10RB/IL15/IL17A/IL2RA/IL4R/LILRA5/LILRB4/MMP12/TNF/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4,20
GO:1903131,GO:1903131,mononuclear cell differentiation,17/81,433/18800,3.5164416250652698e-12,2.84597342188616e-09,1.65211064419733e-09,ADAM8/CD27/CD79B/CD80/CLEC4D/CSF1/DLL1/IL10/IL15/IL2RA/IL4R/LAG3/LILRB4/LTBR/PRTN3/TNFSF8/VCAM1,17
GO:0050863,GO:0050863,regulation of T cell activation,15/81,342/18800,1.6020265780907597e-11,9.724301329010902e-09,5.6450357580619e-09,ADAM8/CD27/CD80/HAVCR2/IL10/IL15/IL2RA/IL4R/LAG3/LILRB4/TNFRSF14/TNFRSF1B/TNFSF8/VCAM1/VSIG4,15
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,13/81,233/18800,2.07493208335004e-11,1.00758701967478e-08,5.84912433601199e-09,CD80/CSF1/HAVCR2/IL10/IL15/IL2RA/LILRB4/TNFRSF14/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1/VSIG4,13
GO:0002697,GO:0002697,regulation of immune effector process,15/81,353/18800,2.5073792812141298e-11,1.01465281579798e-08,5.890141855343361e-09,CD80/HAVCR2/IL10/IL17A/IL4R/LAG3/LILRB4/NECTIN2/NOS2/SPON2/TNF/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,15
GO:0050867,GO:0050867,positive regulation of cell activation,16/81,436/18800,4.502678706279779e-11,1.5617862712639e-08,9.066295921366351e-09,ADAM8/CD27/CD80/CLEC4D/HAVCR2/IL10/IL15/IL2RA/IL4R/LILRA5/LILRB4/NECTIN2/TNF/TNFRSF14/TNFRSF4/VCAM1,16
GO:0042098,GO:0042098,T cell proliferation,12/81,204/18800,7.073032191485269e-11,1.5667081232729e-08,9.094867671301561e-09,CD80/HAVCR2/IL10/IL15/IL2RA/LILRB4/TNFRSF14/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1/VSIG4,12
GO:1902107,GO:1902107,positive regulation of leukocyte differentiation,11/81,157/18800,7.097936308073289e-11,1.5667081232729e-08,9.094867671301561e-09,ADAM8/CD27/CD80/CSF1/IL10/IL15/IL17A/IL2RA/IL4R/LILRB4/TNF,11
GO:1903708,GO:1903708,positive regulation of hemopoiesis,11/81,157/18800,7.097936308073289e-11,1.5667081232729e-08,9.094867671301561e-09,ADAM8/CD27/CD80/CSF1/IL10/IL15/IL17A/IL2RA/IL4R/LILRB4/TNF,11
GO:0001819,GO:0001819,positive regulation of cytokine production,16/81,475/18800,1.59456555678966e-10,3.22633764323775e-08,1.87291515836961e-08,ADAM8/CD80/HAVCR2/IFNGR1/IL10/IL15/IL17A/IL4R/LILRA5/MMP12/NOS2/PRG3/SPON2/TNF/TNFRSF14/TNFRSF8,16
GO:0042129,GO:0042129,regulation of T cell proliferation,11/81,174/18800,2.15007171416333e-10,3.77263280966515e-08,2.1900439313889e-08,CD80/HAVCR2/IL10/IL15/IL2RA/LILRB4/TNFRSF14/TNFRSF1B/TNFSF8/VCAM1/VSIG4,11
GO:1903037,GO:1903037,regulation of leukocyte cell-cell adhesion,14/81,344/18800,2.1856393569813301e-10,3.77263280966515e-08,2.1900439313889e-08,ADAM8/CD27/CD80/HAVCR2/IL10/IL15/IL2RA/IL4R/LAG3/LILRB4/TNF/TNFRSF14/VCAM1/VSIG4,14
GO:0042742,GO:0042742,defense response to bacterium,14/81,364/18800,4.5746798607284006e-10,5.79387246748716e-08,3.36338993928956e-08,CCL20/CLEC4D/HAVCR2/IL10/IL17A/LCN2/NOS2/PRG2/RNASE6/SPON2/TNF/TNFRSF14/TNFRSF1A/TNFSF8,14
GO:0032943,GO:0032943,mononuclear cell proliferation,13/81,300/18800,4.772547337304091e-10,5.79387246748716e-08,3.36338993928956e-08,CD80/CSF1/HAVCR2/IL10/IL15/IL2RA/LILRB4/TNFRSF14/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1/VSIG4,13
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,14/81,381/18800,8.27825121504899e-10,8.55722186166719e-08,4.96753666555639e-08,ADAM8/CD27/CD80/HAVCR2/IL10/IL15/IL2RA/IL4R/LAG3/LILRB4/TNF/TNFRSF14/VCAM1/VSIG4,14
GO:0002443,GO:0002443,leukocyte mediated immunity,15/81,457/18800,9.1272490753778e-10,8.55722186166719e-08,4.96753666555639e-08,C1QA/CD27/GZMB/HAVCR2/IL10/IL4R/LAG3/LILRB4/NECTIN2/NOS2/PTGDS/SPON2/TNF/TNFRSF1B/ULBP2,15
GO:0050900,GO:0050900,leukocyte migration,14/81,384/18800,9.163417150055481e-10,8.55722186166719e-08,4.96753666555639e-08,ADAM8/B4GALT1/CCL11/CCL20/CSF1/CXCL8/CXCL9/IL10/IL17A/PGF/PRTN3/TNF/TNFRSF14/VCAM1,14
GO:0050868,GO:0050868,negative regulation of T cell activation,9/81,125/18800,3.3104737238085803e-09,2.87065364335972e-07,1.66643771284951e-07,CD80/HAVCR2/IL10/IL2RA/IL4R/LAG3/LILRB4/TNFRSF14/VSIG4,9
GO:0034612,GO:0034612,response to tumor necrosis factor,11/81,249/18800,9.450678206035091e-09,6.74889608360388e-07,3.91778889098483e-07,CCL11/CCL20/CXCL8/FAS/IL18BP/TNF/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/VCAM1,11
GO:0032496,GO:0032496,response to lipopolysaccharide,12/81,333/18800,1.85313808201018e-08,1.21605926030289e-06,7.05932259405868e-07,CD80/CXCL8/CXCL9/HAVCR2/IL10/IL18BP/MRC1/NOS2/SPON2/TNF/TNFRSF1B/VCAM1,12
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,9/81,161/18800,3.04920216414002e-08,1.85763418992967e-06,1.0783717074117e-06,CD80/HAVCR2/IL10/IL2RA/IL4R/LAG3/LILRB4/TNFRSF14/VSIG4,9
GO:0071222,GO:0071222,cellular response to lipopolysaccharide,10/81,217/18800,3.136861688102e-08,1.85763418992967e-06,1.0783717074117e-06,CD80/CXCL8/CXCL9/HAVCR2/IL10/MRC1/NOS2/SPON2/TNF/TNFRSF1B,10
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,6/81,44/18800,3.28266904137913e-08,1.87347954346352e-06,1.08757006359909e-06,ADAM8/IL10/PRTN3/RGMA/TNF/TNFRSF1B,6
GO:0070227,GO:0070227,lymphocyte apoptotic process,7/81,75/18800,3.31794153084561e-08,1.87347954346352e-06,1.08757006359909e-06,ADAM8/CD27/EFNA1/FAS/IL10/IL2RA/PDCD1,7
GO:0050870,GO:0050870,positive regulation of T cell activation,10/81,223/18800,4.0592074654083e-08,2.19016793911363e-06,1.27141024472087e-06,ADAM8/CD27/CD80/HAVCR2/IL15/IL2RA/IL4R/LILRB4/TNFRSF14/VCAM1,10
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,9/81,167/18800,4.18599241903966e-08,2.20947599857137e-06,1.28261872976982e-06,IL10/IL17A/IL4R/LILRB4/SPON2/TNF/TNFRSF14/TNFRSF1B/TNFRSF4,9
GO:0032103,GO:0032103,positive regulation of response to external stimulus,13/81,442/18800,4.94177618342755e-08,2.53570275889009e-06,1.47199600891088e-06,ADAM8/CSF1/CXCL8/HAVCR2/IL15/IL17A/LAG3/LILRA5/MMP12/NECTIN2/PGF/TNF/TNFRSF1A,13
GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,5/81,24/18800,5.22179316081156e-08,2.53570275889009e-06,1.47199600891088e-06,ADAM8/IL10/RGMA/TNF/TNFRSF1B,5
GO:0071706,GO:0071706,tumor necrosis factor superfamily cytokine production,9/81,187/18800,1.10715626432328e-07,4.60001859988889e-06,2.67034809037164e-06,ADAM8/HAVCR2/IFNGR1/IL10/IL17A/LILRA5/LILRB4/SPON2/TNFRSF8,9
GO:0006959,GO:0006959,humoral immune response,11/81,317/18800,1.11779694148865e-07,4.60001859988889e-06,2.67034809037164e-06,C1QA/CXCL8/CXCL9/IL17A/PDCD1/PRTN3/REG3A/RNASE6/SPON2/TNF/VSIG4,11
GO:0002819,GO:0002819,regulation of adaptive immune response,9/81,188/18800,1.15880532278695e-07,4.68929887287787e-06,2.72217601265216e-06,CD80/HAVCR2/IL10/IL4R/LILRB4/NECTIN2/TNF/TNFRSF14/TNFRSF1B,9
GO:0071216,GO:0071216,cellular response to biotic stimulus,10/81,256/18800,1.47869851210802e-07,5.69885712285441e-06,3.30823276142463e-06,CD80/CXCL8/CXCL9/HAVCR2/IL10/MRC1/NOS2/SPON2/TNF/TNFRSF1B,10
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,11/81,370/18800,5.23129329984196e-07,1.73994248383785e-05,1.01005071787864e-05,C1QA/CD27/CD80/HAVCR2/IL10/IL18BP/IL4R/LILRB4/NECTIN2/TNF/TNFRSF1B,11
GO:0019730,GO:0019730,antimicrobial humoral response,7/81,122/18800,9.52196810673583e-07,2.85423932878452e-05,1.65690907016495e-05,CXCL8/CXCL9/IL17A/PRTN3/REG3A/RNASE6/SPON2,7
GO:0002643,GO:0002643,regulation of tolerance induction,4/81,20/18800,1.46995255882887e-06,4.19887625039589e-05,2.43748170436144e-05,HAVCR2/IL2RA/LILRB4/PDCD1,4
GO:0050731,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,8/81,190/18800,1.60863294555656e-06,4.54158231605967e-05,2.63642535385585e-05,CD80/EFNA1/GFRA1/IL15/LILRA5/TNF/TNFRSF14/TNFRSF1A,8
GO:0002687,GO:0002687,positive regulation of leukocyte migration,7/81,141/18800,2.51604690742562e-06,6.94200214912431e-05,4.02988852756328e-05,ADAM8/CCL20/CSF1/CXCL8/PGF/TNF/TNFRSF14,7
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,8/81,211/18800,3.51290227831682e-06,9.27100731712308e-05,5.38189490922908e-05,B4GALT1/CCL11/IL10/MMP12/NRP2/PGF/REG3A/TNF,8
GO:1902993,GO:1902993,positive regulation of amyloid precursor protein catabolic process,4/81,25/18800,3.77558171867795e-06,9.85711012145169e-05,5.72213233877734e-05,EFNA1/IFNGR1/SPON1/TNF,4
GO:0031349,GO:0031349,positive regulation of defense response,9/81,289/18800,4.19359177873922e-06,0.0001049694931832,6.09356417985004e-05,ADAM8/HAVCR2/IL15/LAG3/LILRA5/MMP12/NECTIN2/TNF/TNFRSF1A,9
GO:0002367,GO:0002367,cytokine production involved in immune response,6/81,100/18800,4.57711606168958e-06,0.0001117549258714,6.48746404846175e-05,IL10/LILRB4/SPON2/TNF/TNFRSF14/TNFRSF1B,6
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,5/81,57/18800,4.60275641974508e-06,0.0001117549258714,6.48746404846175e-05,ADAM8/CD27/EFNA1/IL10/PDCD1,5
GO:0007568,GO:0007568,aging,7/81,163/18800,6.56994894761872e-06,0.0001504890192907,8.73600957384455e-05,C1QA/GFRA1/IL10/IL15/RETN/TNFRSF1B/VCAM1,7
GO:0030198,GO:0030198,extracellular matrix organization,9/81,307/18800,6.83759494989041e-06,0.0001537192642438,8.92352791218641e-05,ADAM8/B4GALT1/MMP10/MMP12/SMOC1/TNF/TNFRSF11B/TNFRSF1A/TNFRSF1B,9
GO:0002440,GO:0002440,production of molecular mediator of immune response,9/81,312/18800,7.7867758827609e-06,0.0001658446652924,9.62741727333041e-05,IL10/IL17A/IL4R/LILRB4/SPON2/TNF/TNFRSF14/TNFRSF1B/TNFRSF4,9
GO:0030595,GO:0030595,leukocyte chemotaxis,8/81,236/18800,8.00541835944846e-06,0.0001681954106825,9.7638799490106e-05,ADAM8/CCL11/CCL20/CSF1/CXCL8/CXCL9/IL10/PGF,8
GO:0043410,GO:0043410,positive regulation of MAPK cascade,11/81,491/18800,8.03569507379364e-06,0.0001681954106825,9.7638799490106e-05,ADAM8/CCL11/CCL20/CD27/EFNA1/GDF15/HAVCR2/IGFBP4/LILRA5/LTBR/TNF,11
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,5/81,72/18800,1.46234751471187e-05,0.0002863370778806,0.0001662209950933,GZMB/HAVCR2/LAG3/NECTIN2/ULBP2,5
GO:0032102,GO:0032102,negative regulation of response to external stimulus,10/81,429/18800,1.52572316846524e-05,0.0002963564682426,0.0001720373324273,ANGPT2/HAVCR2/IL10/IL2RA/MMP12/RGMA/TNF/TNFRSF1A/TNFRSF1B/VSIG4,10
GO:0045765,GO:0045765,regulation of angiogenesis,9/81,345/18800,1.73603621760642e-05,0.0003345314235197,0.0001941982034565,ANGPT2/CCL11/CXCL8/DLL1/EFNA1/IL10/PGF/THBS2/TNF,9
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,6/81,131/18800,2.15856391783423e-05,0.0003970449388258,0.0002304878058995,GZMB/HAVCR2/LAG3/NECTIN2/NOS2/ULBP2,6
GO:0009612,GO:0009612,response to mechanical stimulus,7/81,201/18800,2.56221867438281e-05,0.0004642587269702,0.0002695059548309,ANGPT2/FAS/LTBR/RETN/TNF/TNFRSF1A/TNFRSF8,7
GO:0014002,GO:0014002,astrocyte development,4/81,43/18800,3.4725916995228e-05,0.0006109748294522,0.0003546758417742,C1QA/DLL1/IFNGR1/TNF,4
GO:1901741,GO:1901741,positive regulation of myoblast fusion,3/81,16/18800,4.14386051870378e-05,0.000722362421179,0.0004193372418099,CXCL9/GDF15/IL4R,3
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,7/81,221/18800,4.69113884110065e-05,0.0007951156410027,0.0004615710757403,CD27/FAS/IL19/LTBR/TNF/TNFRSF1A/TNFRSF1B,7
GO:0009615,GO:0009615,response to virus,9/81,392/18800,4.71567760726528e-05,0.0007951156410027,0.0004615710757403,CCL11/CXCL9/IFNGR1/IL10RB/IL15/MMP12/RNASE6/SPON2/TNF,9
GO:0002544,GO:0002544,chronic inflammatory response,3/81,17/18800,5.01620451370748e-05,0.0008285268407674,0.000480966548074,IL10/TNF/VCAM1,3
GO:0044409,GO:0044409,entry into host,6/81,153/18800,5.16915167685128e-05,0.0008480202886077,0.000492282652582,CD80/CXCL8/MRC1/NECTIN2/TNFRSF14/TNFRSF4,6
GO:0002439,GO:0002439,chronic inflammatory response to antigenic stimulus,2/81,3/18800,5.48510803294872e-05,0.0008704472094117,0.0005053016619276,IL10/TNF,2
GO:0002874,GO:0002874,regulation of chronic inflammatory response to antigenic stimulus,2/81,3/18800,5.48510803294872e-05,0.0008704472094117,0.0005053016619276,IL10/TNF,2
GO:0060763,GO:0060763,mammary duct terminal end bud growth,2/81,3/18800,5.48510803294872e-05,0.0008704472094117,0.0005053016619276,CCL11/CSF1,2
GO:0046631,GO:0046631,alpha-beta T cell activation,6/81,158/18800,6.18280690884163e-05,0.0009577235482317,0.0005559662841768,CD80/IL15/IL4R/LILRB4/TNFRSF14/TNFSF8,6
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,5/81,97/18800,6.1928581990275e-05,0.0009577235482317,0.0005559662841768,IL17A/IL4R/LILRB4/NOS2/TNF,5
GO:0034205,GO:0034205,amyloid-beta formation,4/81,56/18800,9.90509867181725e-05,0.0014845419490847,0.0008617886368787,EFNA1/IFNGR1/SPON1/TNF,4
GO:0003332,GO:0003332,negative regulation of extracellular matrix constituent secretion,2/81,4/18800,0.0001093949020021,0.0016295142457742,0.0009459462304221,TNFRSF1A/TNFRSF1B,2
GO:0050673,GO:0050673,epithelial cell proliferation,9/81,443/18800,0.0001200854462315,0.0017670755360611,0.0010258016746665,B4GALT1/CCL11/IGFBP4/IL10/MMP12/NRP2/PGF/REG3A/TNF,9
GO:0002833,GO:0002833,positive regulation of response to biotic stimulus,6/81,180/18800,0.0001268972263917,0.0018449488962817,0.0010710077916072,ADAM8/HAVCR2/IL17A/LAG3/MMP12/NECTIN2,6
GO:0002526,GO:0002526,acute inflammatory response,5/81,113/18800,0.000127828325734,0.0018474236600131,0.0010724444120166,ADAM8/B4GALT1/REG3A/TNF/VCAM1,5
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,4/81,61/18800,0.0001384549009637,0.0019606902130503,0.001138196564326,DSC2/IL10/TNF/VCAM1,4
GO:0001906,GO:0001906,cell killing,6/81,185/18800,0.000147382266259,0.0020122544312774,0.0011681300110467,GZMB/HAVCR2/LAG3/NECTIN2/NOS2/ULBP2,6
GO:0031348,GO:0031348,negative regulation of defense response,7/81,268/18800,0.000156535504417,0.0021018543135114,0.0012201434690851,HAVCR2/IL10/IL2RA/MMP12/TNFRSF1A/TNFRSF1B/VSIG4,7
GO:0071346,GO:0071346,cellular response to interferon-gamma,5/81,118/18800,0.0001566868330912,0.0021018543135114,0.0012201434690851,CCL11/CCL20/MRC1/NOS2/TNF,5
GO:0031100,GO:0031100,animal organ regeneration,4/81,65/18800,0.0001772974140242,0.0023395550067983,0.0013581306486182,ANGPT2/IL10/PGF/TNF,4
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/81,5/18800,0.0001818143323949,0.0023861902651615,0.0013852027941781,TNFRSF1A/TNFRSF1B,2
GO:0050926,GO:0050926,regulation of positive chemotaxis,3/81,26/18800,0.0001865060536675,0.0024295633921438,0.0014103812460247,ANGPT2/CXCL8/PGF,3
GO:0002366,GO:0002366,leukocyte activation involved in immune response,7/81,285/18800,0.0002281698317212,0.0028238396126241,0.0016392617884781,CD80/CLEC4D/DLL1/HAVCR2/IL10/IL4R/PTGDS,7
GO:0071260,GO:0071260,cellular response to mechanical stimulus,4/81,70/18800,0.0002362233841868,0.0028677518840284,0.0016647532180326,FAS/LTBR/TNFRSF1A/TNFRSF8,4
GO:0150076,GO:0150076,neuroinflammatory response,4/81,73/18800,0.0002776864186831,0.0031667045109399,0.0018382976416147,C1QA/IFNGR1/TNF/TNFRSF1B,4
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,4/81,74/18800,0.000292598587985,0.0032701788846814,0.0018983653544561,DLL1/NRP2/PGF/VCAM1,4
GO:0002534,GO:0002534,cytokine production involved in inflammatory response,4/81,75/18800,0.0003080769402593,0.0034000491406805,0.0019737560909439,IL17A/LILRB4/NOS2/TNF,4
GO:0016064,GO:0016064,immunoglobulin mediated immune response,6/81,216/18800,0.0003399645889425,0.0037181712700562,0.0021584285661169,C1QA/CD27/IL10/IL4R/NECTIN2/TNF,6
GO:0045089,GO:0045089,positive regulation of innate immune response,5/81,140/18800,0.0003468648140279,0.0037597668234811,0.0021825751221023,ADAM8/HAVCR2/LAG3/MMP12/NECTIN2,5
GO:0071496,GO:0071496,cellular response to external stimulus,7/81,309/18800,0.0003721777452025,0.003980826279083,0.0023109019282459,DSC2/FAS/IL15/LTBR/TNFRSF1A/TNFRSF8/VCAM1,7
GO:0019058,GO:0019058,viral life cycle,7/81,317/18800,0.0004337840246697,0.0045594268913341,0.0026467842744717,CD80/CXCL8/MRC1/NECTIN2/TNF/TNFRSF14/TNFRSF4,7
GO:0070482,GO:0070482,response to oxygen levels,7/81,324/18800,0.0004941516205948,0.0051493568017351,0.0029892433701219,ADAM8/ANGPT2/FAS/NOS2/PGF/TNF/VCAM1,7
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,4/81,85/18800,0.0004967633338002,0.0051544503182345,0.0029922001977439,HAVCR2/LAG3/NECTIN2/NOS2,4
GO:0097527,GO:0097527,necroptotic signaling pathway,2/81,8/18800,0.000504818519394,0.0051936413774942,0.0030149509253727,FAS/TNF,2
GO:0003176,GO:0003176,aortic valve development,3/81,37/18800,0.0005386664382849,0.0054953029922516,0.0031900679383616,EFNA1/TNFRSF1A/TNFRSF1B,3
GO:0006924,GO:0006924,activation-induced cell death of T cells,2/81,9/18800,0.0006472373255325,0.006414253985278,0.003723526439906,FAS/IL2RA,2
GO:0030574,GO:0030574,collagen catabolic process,3/81,42/18800,0.0007836342422503,0.0076412206433084,0.0044357905321208,MMP10/MMP12/PRTN3,3
GO:0035860,GO:0035860,glial cell-derived neurotrophic factor receptor signaling pathway,2/81,10/18800,0.000806784890219,0.0077121012340625,0.0044769372896946,GDF15/GFRA1,2
GO:0045625,GO:0045625,regulation of T-helper 1 cell differentiation,2/81,10/18800,0.000806784890219,0.0077121012340625,0.0044769372896946,CD80/IL4R,2
GO:1990868,GO:1990868,response to chemokine,4/81,97/18800,0.0008175069172578,0.0077424402087621,0.004494549310471,CCL11/CCL20/CXCL8/CXCL9,4
GO:0070997,GO:0070997,neuron death,7/81,353/18800,0.0008195251786045,0.0077424402087621,0.004494549310471,ADAM8/C1QA/CSF1/FAS/IL10/TNF/TNFRSF1B,7
GO:0007259,GO:0007259,receptor signaling pathway via JAK-STAT,5/81,173/18800,0.0009074690165417,0.0085070840624069,0.0049384312666101,IL10/IL10RB/IL15/TNF/TNFRSF1A,5
GO:0031341,GO:0031341,regulation of cell killing,4/81,100/18800,0.0009162052276704,0.0085559472799376,0.0049667967605291,HAVCR2/LAG3/NECTIN2/NOS2,4
GO:0002920,GO:0002920,regulation of humoral immune response,3/81,45/18800,0.000959666402451,0.0088260228225426,0.0051235778025598,IL17A/TNF/VSIG4,3
GO:0042487,GO:0042487,regulation of odontogenesis of dentin-containing tooth,2/81,11/18800,0.0009833146331584,0.0089040751929277,0.0051688878363523,CSF1/TNFRSF11B,2
GO:1900222,GO:1900222,negative regulation of amyloid-beta clearance,2/81,11/18800,0.0009833146331584,0.0089040751929277,0.0051688878363523,IFNGR1/TNF,2
GO:0002269,GO:0002269,leukocyte activation involved in inflammatory response,3/81,50/18800,0.0013051966918809,0.0109704113286776,0.0063684127152949,C1QA/IFNGR1/TNF,3
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,3/81,50/18800,0.0013051966918809,0.0109704113286776,0.0063684127152949,DLL1/NRP2/PGF,3
GO:0043457,GO:0043457,regulation of cellular respiration,3/81,50/18800,0.0013051966918809,0.0109704113286776,0.0063684127152949,IL10RB/NOS2/TNF,3
GO:0031099,GO:0031099,regeneration,5/81,188/18800,0.0013142110711376,0.0110031188990422,0.0063873997250574,ANGPT2/IL10/PGF/RGMA/TNF,5
GO:0071347,GO:0071347,cellular response to interleukin-1,4/81,111/18800,0.001350207956644,0.0111122181272314,0.0064507327115073,CCL11/CCL20/CXCL8/IL17A,4
GO:0045605,GO:0045605,negative regulation of epidermal cell differentiation,2/81,13/18800,0.0013867389178546,0.0111122181272314,0.0064507327115073,DLL1/REG3A,2
GO:0045683,GO:0045683,negative regulation of epidermis development,2/81,13/18800,0.0013867389178546,0.0111122181272314,0.0064507327115073,DLL1/REG3A,2
GO:1900121,GO:1900121,negative regulation of receptor binding,2/81,13/18800,0.0013867389178546,0.0111122181272314,0.0064507327115073,IL10/RGMA,2
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,2/81,13/18800,0.0013867389178546,0.0111122181272314,0.0064507327115073,TNFRSF1A/TNFRSF1B,2
GO:0042176,GO:0042176,regulation of protein catabolic process,7/81,395/18800,0.0015686226957559,0.0122858577590179,0.0071320400326562,ADAM8/EFNA1/IL10/NOS2/RGMA/TNF/TNFRSF1B,7
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/81,14/18800,0.0016133448691918,0.0123182432150872,0.0071508400524589,TNFRSF1A/TNFRSF1B,2
GO:0045661,GO:0045661,regulation of myoblast differentiation,3/81,54/18800,0.0016314413404094,0.0123215964719906,0.0071527866452767,CXCL9/DLL1/TNF,3
GO:1904645,GO:1904645,response to amyloid-beta,3/81,55/18800,0.001720239291401,0.0128120889555883,0.0074375215085115,MMP12/TNF/VCAM1,3
GO:0022612,GO:0022612,gland morphogenesis,4/81,123/18800,0.0019685700572945,0.0144401453145356,0.0083826214238112,CCL11/CSF1/TNC/TNF,4
GO:0050807,GO:0050807,regulation of synapse organization,5/81,209/18800,0.0020918691089722,0.0152144200758424,0.0088320941999275,EFNA1/IL10/NRP2/THBS2/TNF,5
GO:0140253,GO:0140253,cell-cell fusion,3/81,59/18800,0.0021054551670029,0.0152144200758424,0.0088320941999275,CXCL9/GDF15/IL4R,3
GO:1902893,GO:1902893,regulation of miRNA transcription,3/81,59/18800,0.0021054551670029,0.0152144200758424,0.0088320941999275,IL10/LILRB4/TNF,3
GO:0061614,GO:0061614,miRNA transcription,3/81,60/18800,0.0022094370710524,0.0158245227389835,0.0091862637420874,IL10/LILRB4/TNF,3
GO:1901214,GO:1901214,regulation of neuron death,6/81,313/18800,0.0023139653351524,0.0165244348051475,0.0095925683708022,ADAM8/C1QA/CSF1/IL10/TNF/TNFRSF1B,6
GO:0050803,GO:0050803,regulation of synapse structure or activity,5/81,215/18800,0.002365362042421,0.0168272742726788,0.0097683691368754,EFNA1/IL10/NRP2/THBS2/TNF,5
GO:0048532,GO:0048532,anatomical structure arrangement,2/81,17/18800,0.0023910253805906,0.0168272742726788,0.0097683691368754,DLL1/NRP2,2
GO:1901550,GO:1901550,regulation of endothelial cell development,2/81,17/18800,0.0023910253805906,0.0168272742726788,0.0097683691368754,TNF/TNFRSF1A,2
GO:1903140,GO:1903140,regulation of establishment of endothelial barrier,2/81,17/18800,0.0023910253805906,0.0168272742726788,0.0097683691368754,TNF/TNFRSF1A,2
GO:0002712,GO:0002712,regulation of B cell mediated immunity,3/81,62/18800,0.0024268467900605,0.0168353828750483,0.0097730762462887,IL10/NECTIN2/TNF,3
GO:0002889,GO:0002889,regulation of immunoglobulin mediated immune response,3/81,62/18800,0.0024268467900605,0.0168353828750483,0.0097730762462887,IL10/NECTIN2/TNF,3
GO:0050918,GO:0050918,positive chemotaxis,3/81,64/18800,0.0026570636511333,0.0179204181804213,0.0104029480376242,ANGPT2/CXCL8/PGF,3
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,2/81,18/18800,0.0026824026088444,0.0180208288519788,0.0104612372465098,HAVCR2/TNF,2
GO:2001235,GO:2001235,positive regulation of apoptotic signaling pathway,4/81,134/18800,0.0026867957349325,0.0180208288519788,0.0104612372465098,FAS/IL19/LTBR/TNF,4
GO:0014823,GO:0014823,response to activity,3/81,65/18800,0.0027770523400256,0.018372433464802,0.0106653465747723,ANGPT2/IL10/TNF,3
GO:2000272,GO:2000272,negative regulation of signaling receptor activity,3/81,65/18800,0.0027770523400256,0.018372433464802,0.0106653465747723,IL18BP/LILRB4/TNF,3
GO:0031645,GO:0031645,negative regulation of nervous system process,2/81,19/18800,0.0029896220035106,0.0195655046483122,0.0113579340692318,IL10/TNF,2
GO:0031667,GO:0031667,response to nutrient levels,7/81,446/18800,0.0031006834448404,0.0200224984150869,0.011623222655771,DSC2/FAS/GDF15/IL15/TNF/TNFRSF11B/VCAM1,7
GO:0070555,GO:0070555,response to interleukin-1,4/81,141/18800,0.0032272224390128,0.0207843397398495,0.0120654777211734,CCL11/CCL20/CXCL8/IL17A,4
GO:0042113,GO:0042113,B cell activation,6/81,336/18800,0.0032864399384008,0.0210546058235023,0.0122223693738271,CD27/CD79B/DLL1/IL10/TNFRSF4/VCAM1,6
GO:0002837,GO:0002837,regulation of immune response to tumor cell,2/81,20/18800,0.0033125450677833,0.0210546058235023,0.0122223693738271,HAVCR2/NECTIN2,2
GO:0045063,GO:0045063,T-helper 1 cell differentiation,2/81,21/18800,0.0036510341785373,0.0230252233389318,0.0133663288176666,CD80/IL4R,2
GO:0035584,GO:0035584,calcium-mediated signaling using intracellular calcium source,2/81,22/18800,0.0040049525815224,0.0249333970972729,0.014474039154274,CCL20/VCAM1,2
GO:2000810,GO:2000810,regulation of bicellular tight junction assembly,2/81,22/18800,0.0040049525815224,0.0249333970972729,0.014474039154274,IL17A/TNF,2
GO:0006809,GO:0006809,nitric oxide biosynthetic process,3/81,75/18800,0.0041627819778133,0.0250264684923145,0.0145280678536413,IL10/NOS2/TNF,3
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,DLL1,1
GO:0045994,GO:0045994,positive regulation of translational initiation by iron,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,TNF,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,NECTIN2,1
GO:0060611,GO:0060611,mammary gland fat development,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,CSF1,1
GO:0060739,GO:0060739,mesenchymal-epithelial cell signaling involved in prostate gland development,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,TNC,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,DLL1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,VCAM1,1
GO:0061048,GO:0061048,negative regulation of branching involved in lung morphogenesis,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,TNF,1
GO:0140460,GO:0140460,response to Gram-negative bacterium,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,TNF,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,CSF1,1
GO:2000196,GO:2000196,positive regulation of female gonad development,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,RETN,1
GO:2000872,GO:2000872,positive regulation of progesterone secretion,1/81,1/18800,0.0043085106382979,0.0250264684923145,0.0145280678536413,RETN,1
GO:1900120,GO:1900120,regulation of receptor binding,2/81,23/18800,0.0043741643865809,0.0251074967626918,0.0145751054215054,IL10/RGMA,2
GO:0002764,GO:0002764,immune response-regulating signaling pathway,7/81,482/18800,0.0047367741592344,0.0269341631349442,0.015635500059694,BTN2A1/CD79B/CLEC4D/HAVCR2/LILRB4/NECTIN2/TNF,7
GO:0035821,GO:0035821,modulation of process of another organism,2/81,25/18800,0.005157928934233,0.0286892616961953,0.016654349003384,NOS2/REG3A,2
GO:0021675,GO:0021675,nerve development,3/81,81/18800,0.0051635944650895,0.0286892616961953,0.016654349003384,LRIG1/NRP2/VCAM1,3
GO:0045445,GO:0045445,myoblast differentiation,3/81,81/18800,0.0051635944650895,0.0286892616961953,0.016654349003384,CXCL9/DLL1/TNF,3
GO:0046209,GO:0046209,nitric oxide metabolic process,3/81,81/18800,0.0051635944650895,0.0286892616961953,0.016654349003384,IL10/NOS2/TNF,3
GO:2001057,GO:2001057,reactive nitrogen species metabolic process,3/81,82/18800,0.0053432247431126,0.0295520493764865,0.0171552042465601,IL10/NOS2/TNF,3
GO:0060561,GO:0060561,apoptotic process involved in morphogenesis,2/81,26/18800,0.0055722141742802,0.0304030022812412,0.0176491893065906,TNFRSF1A/TNFRSF1B,2
GO:1903034,GO:1903034,regulation of response to wounding,4/81,166/18800,0.0057559056627286,0.0313348406930609,0.0181901290592251,IL10/REG3A/RGMA/TNF,4
GO:0002418,GO:0002418,immune response to tumor cell,2/81,27/18800,0.0060012578019135,0.0322368450067391,0.0187137498760182,HAVCR2/NECTIN2,2
GO:0034103,GO:0034103,regulation of tissue remodeling,3/81,86/18800,0.0060991864177588,0.0326905620801733,0.0189771363155086,ADAM8/IL15/TNFRSF11B,3
GO:1903203,GO:1903203,regulation of oxidative stress-induced neuron death,2/81,29/18800,0.0069030944935567,0.0361274467687847,0.0209722757406584,IL10/TNF,2
GO:0042475,GO:0042475,odontogenesis of dentin-containing tooth,3/81,90/18800,0.0069160005521714,0.0361274467687847,0.0209722757406584,CSF1/RELT/TNFRSF11B,3
GO:0043534,GO:0043534,blood vessel endothelial cell migration,4/81,175/18800,0.0069189714775473,0.0361274467687847,0.0209722757406584,ANGPT2/EFNA1/EPHB4/TNF,4
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,5/81,279/18800,0.0071122099474188,0.0369773998979294,0.0214656804228421,DSC2/IL10/NECTIN2/REG3A/VCAM1,5
GO:0001659,GO:0001659,temperature homeostasis,4/81,177/18800,0.0071970147589741,0.0372587459163947,0.0216290040674814,IL15/IL4R/LCN2/TNF,4
GO:0060055,GO:0060055,angiogenesis involved in wound healing,2/81,31/18800,0.0078623958878224,0.0389507651611717,0.0226112349565633,B4GALT1/TNF,2
GO:0046330,GO:0046330,positive regulation of JNK cascade,3/81,96/18800,0.0082578463688538,0.0389507651611717,0.0226112349565633,CD27/LTBR/TNF,3
GO:0071353,GO:0071353,cellular response to interleukin-4,2/81,32/18800,0.0083632734938962,0.0389507651611717,0.0226112349565633,IL4R/MRC1,2
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,4/81,185/18800,0.0083829265569085,0.0389507651611717,0.0226112349565633,CCL11/CSF1/IL10/TNF,4
GO:0002040,GO:0002040,sprouting angiogenesis,4/81,186/18800,0.0085396195230255,0.0389507651611717,0.0226112349565633,DLL1/EPHB4/IL10/PGF,4
GO:0001694,GO:0001694,histamine biosynthetic process,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,PRG3,1
GO:0002037,GO:0002037,negative regulation of L-glutamate import across plasma membrane,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,TNF,1
GO:0005988,GO:0005988,lactose metabolic process,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,B4GALT1,1
GO:0005989,GO:0005989,lactose biosynthetic process,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,B4GALT1,1
GO:0021649,GO:0021649,vestibulocochlear nerve structural organization,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,NRP2,1
GO:0021693,GO:0021693,cerebellar Purkinje cell layer structural organization,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,DLL1,1
GO:0030382,GO:0030382,sperm mitochondrion organization,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,NECTIN2,1
GO:0060302,GO:0060302,negative regulation of cytokine activity,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,IL10,1
GO:0060370,GO:0060370,susceptibility to T cell mediated cytotoxicity,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,NECTIN2,1
GO:0060557,GO:0060557,positive regulation of vitamin D biosynthetic process,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,TNF,1
GO:0061552,GO:0061552,ganglion morphogenesis,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,NRP2,1
GO:0072564,GO:0072564,blood microparticle formation,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,TNF,1
GO:0097102,GO:0097102,endothelial tip cell fate specification,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,DLL1,1
GO:0120190,GO:0120190,negative regulation of bile acid secretion,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,TNF,1
GO:0140039,GO:0140039,cell-cell adhesion in response to extracellular stimulus,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,VCAM1,1
GO:1904835,GO:1904835,dorsal root ganglion morphogenesis,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,NRP2,1
GO:1904905,GO:1904905,negative regulation of endothelial cell-matrix adhesion via fibronectin,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,MMP12,1
GO:1990267,GO:1990267,response to transition metal nanoparticle,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,TNF,1
GO:1990268,GO:1990268,response to gold nanoparticle,1/81,2/18800,0.0085986862135041,0.0389507651611717,0.0226112349565633,TNF,1
GO:0036475,GO:0036475,neuron death in response to oxidative stress,2/81,33/18800,0.0088781320908168,0.0396251924935724,0.0230027454907194,IL10/TNF,2
GO:0048566,GO:0048566,embryonic digestive tract development,2/81,33/18800,0.0088781320908168,0.0396251924935724,0.0230027454907194,CXCL8/TNF,2
GO:0050764,GO:0050764,regulation of phagocytosis,3/81,99/18800,0.0089821973481684,0.0399428116508296,0.0231871259864999,IL15/PRTN3/TNF,3
GO:0070670,GO:0070670,response to interleukin-4,2/81,34/18800,0.0094068449847186,0.0416605414562943,0.024184282064501,IL4R/MRC1,2
GO:0050808,GO:0050808,synapse organization,6/81,419/18800,0.0094199494479017,0.0416605414562943,0.024184282064501,C1QA/EFNA1/IL10/NRP2/THBS2/TNF,6
GO:0008630,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,3/81,101/18800,0.0094851540119611,0.0417966496207651,0.0242632939574285,TNF/TNFRSF1A/TNFRSF1B,3
GO:0032963,GO:0032963,collagen metabolic process,3/81,101/18800,0.0094851540119611,0.0417966496207651,0.0242632939574285,MMP10/MMP12/PRTN3,3
GO:0010614,GO:0010614,negative regulation of cardiac muscle hypertrophy,2/81,35/18800,0.0099492862903094,0.0436945976120262,0.0253650681533439,TNFRSF1A/TNFRSF1B,2
GO:0001763,GO:0001763,morphogenesis of a branching structure,4/81,199/18800,0.0107536934093817,0.046792056627202,0.0271631682232825,CCL11/CSF1/IL10/TNF,4
GO:0042092,GO:0042092,type 2 immune response,2/81,37/18800,0.0110748546114307,0.0480174053509887,0.027874493091552,IL10/IL4R,2
GO:0002064,GO:0002064,epithelial cell development,4/81,203/18800,0.0115028685920924,0.0496073977648319,0.0287974965781279,B4GALT1/DLL1/TNF/TNFRSF1A,4
